UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 7.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 33,915 shares of the company’s stock after acquiring an additional 2,458 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.19% of Addus HomeCare worth $4,512,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. UMB Bank n.a. increased its position in shares of Addus HomeCare by 64.2% during the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after purchasing an additional 88 shares during the last quarter. Quest Partners LLC acquired a new stake in shares of Addus HomeCare during the second quarter valued at about $31,000. Innealta Capital LLC acquired a new stake in shares of Addus HomeCare during the second quarter valued at about $44,000. Farther Finance Advisors LLC increased its position in shares of Addus HomeCare by 9,150.0% during the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after acquiring an additional 366 shares during the last quarter. Finally, Sandia Investment Management LP acquired a new position in shares of Addus HomeCare in the 2nd quarter worth approximately $58,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Stock Performance

ADUS stock opened at $120.90 on Thursday. The company’s 50 day moving average price is $125.76 and its 200 day moving average price is $124.29. The firm has a market capitalization of $2.19 billion, a price-to-earnings ratio of 27.67, a PEG ratio of 2.11 and a beta of 1.02. Addus HomeCare Co. has a fifty-two week low of $85.94 and a fifty-two week high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, November 4th. The company reported $1.30 EPS for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. The company had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.03 EPS. Equities analysts forecast that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In other news, CEO R Dirk Allison sold 12,500 shares of the company’s stock in a transaction on Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the transaction, the chief executive officer now owns 141,897 shares in the company, valued at approximately $17,476,034.52. This represents a 8.10 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction on Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the sale, the executive vice president now owns 10,217 shares in the company, valued at $1,236,257. This represents a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.60% of the stock is owned by insiders.

Wall Street Analyst Weigh In

ADUS has been the topic of a number of research analyst reports. KeyCorp assumed coverage on Addus HomeCare in a research report on Friday, October 11th. They issued an “overweight” rating and a $150.00 target price on the stock. Stephens boosted their price objective on Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a report on Wednesday, November 6th. Macquarie restated an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a report on Monday, November 4th. Royal Bank of Canada reiterated an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a research note on Thursday, November 14th. Finally, Oppenheimer raised their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. One research analyst has rated the stock with a sell rating, eight have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Addus HomeCare presently has an average rating of “Moderate Buy” and an average price target of $131.63.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.